References
- Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol. 2014;15:23–34. doi: 10.1016/S1470-2045(13)70546-1.
- Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ. 2015;350. doi: 10.1136/bmj.g7773.
- Zahl PH, Jørgensen KJ, Gøtzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer. 2013;109:2014–9. doi: 10.1038/bjc.2013.427.
- Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009;101:S125–9. doi: 10.1038/sj.bjc.6605402.
- Woods LM, Coleman MP, Lawrence G, Rashbass J, Berrino F, Rachet B. Evidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with National Cancer Registry data. BMJ. 2011;342. doi: 10.1136/bmj.d3399.
- Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087. doi: 10.1136/bmj.m4087.
- Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49:2187– 98. doi: 10.1016/j.ejca.2013.01.025.
- Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92–107. doi: 10.1038/bjc.2015.48.
- Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, et al. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy (New York). 2013;112(1–2):148–55. doi: 10.1016/j.healthpol.2013.03.021.
- Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: a scoping literature review. Lung Cancer. 2017;112:156–64. doi: 10.1016/j.lungcan.2017.08.011.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492.
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. doi: 10.1016/S0140-6736(17)33326-3.
- Zadnik V, Žagar T, Primic Žakelj M. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdr Varst. 2016;55:144–51. doi: 10.1515/sjph-2016-0012.
- Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231–72. doi: 10.1016/S1470-2045(15)00205-3.
- de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13. doi: 10.1056/nejmoa1911793.
- Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi: 10.1056/nejmoa1102873.
- Harris M, Taylor G. How health system factors affect primary care practitioners’ decisions to refer patients for further investigation: protocol for a pan-European ecological study. BMC Health Serv Res. 2018;18:338. doi: 10.1186/s12913-018-3170-2.
- Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, et al. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open. 2015;5:e007212. doi: 10.1136/ bmjopen-2014-007212.
- Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83:457–502. doi: 10.1111/j.1468-0009.2005.00409.x.
- Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Br J Gen Pract. 2011;61:e508-12. doi: 10.3399/bjgp11X588484.
- Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer. 2009;101:S5–8. doi: 10.1038/sj.bjc.6605383.
- Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127–38. doi: 10.1016/S0140-6736(10)62231-3.
- Harris M, Frey P, Esteva M, Gašparović Babić S, Marzo-Castillejo M, Petek D, et al. How the probability of presentation to a primary care clinician correlates with cancer survival rates: an European survey using vignettes. Scand J Prim Health Care. 2017;35:27–34. doi: 10.1080/02813432.2017.1288692.
- Prades J, Espinás JA, Font R, Argimon JM, Borrs JM. Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer. 2011;105:753–9. doi: 10.1038/bjc.2011.308.
- Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians - a national Danish project. Health Policy (New York). 2012;105:65–70. doi: 10.1016/j.healthpol.2011.11.001.
- Department of Health. The NHS Cancer Plan. Dep Heal. 2000:1–98. Accessed 3rd November, 2020 at: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014513.pdf
- Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardio-thoracic Surg. 1997;12:880–4. doi: 10.1016/S1010-7940(97)00275-3.
- Lo DS, Zeldin RA, Skrastins R, Fraser IM, Newman H, Monavvari A, et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol. 2007;2:1001–6. doi: 10.1097/JTO.0b013e318158d4b6.
- Nicholson BD, Oke JL, Rose PW, Mant D. Variation in direct access to tests to investigate cancer: a survey of english general practitioners. PLoS One. 2016;11: e0159725. doi: 10.1371/journal.pone.0159725.
- Sahota IS, Kostaras X, Hagen NA. Improving access to cancer guidelines: feedback from health care professionals. Curr Oncol. 2015;22:392–8. doi: 10.3747/co.22.2704.
- Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284. doi: 10.1186/1472-6963-11-284.
- Maclean R, Jeffreys M, Ives A, Jones T, Verne J, Ben-Shlomo Y. Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information. BMC Cancer. 2015;15:500. doi: 10.1186/s12885-015-1497-1.
- Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. General practitioner characteristics and delay in cancer diagnosis: a population-based cohort study. BMC Fam Pract. 2011;12:100. doi: 10.1186/1471-2296-12-100.
- Aldridge S, The Strategy Unit. Early diagnosis of cancer: evidence review. 2020. Accessed 23rd August, 2021 at: https://www.strategyunitwm.nhs.uk/sites/default/files/2021-04/20210407Earlydiagnosis of cancer_FINAL_0.pdf.
- Evans SC, Roberts MC, Keeley JW, Blossom JB, Amaro CM, Garcia AM, et al. Vignette methodologies for studying clinicians’ decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Heal Psychol. 2015;15:160–70. doi: 10.1016/j.ijchp.2014.12.001.
- Hrisos S, Eccles MP, Francis JJ, Dickinson HO, Kaner EF, Beyer F, et al. Are there valid proxy measures of clinical behaviour? A systematic review. Implement Sci. 2009;4. doi: 10.1186/1748-5908-4-37.
- Bradley SH, Grice A, Neal RD, Abraham S, Rodriguez Lopez R, Shinkins B, et al. Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. Br J Gen Pract. 2019;69:E827–35. doi: 10.3399/bjgp19X706853.
- Stapley S, Sharp D, Hamilton W. Negative chest X-rays in primary care patients with lung cancer. Br J Gen Pract. 2006;56:570–3.
- Kennedy MPT, Cheyne L, Darby M, Plant P, Milton R, Robson JM, et al. Lung cancer stage-shift following a symptom awareness campaign. Thorax. 2018;73:1128–36. doi: 10.1136/thoraxjnl-2018-211842.
- Bradley SH, Kennedy MPT, Neal RD. Recognising lung cancer in primary care. Adv Ther. 2019;36:19–30. doi: 10.1007/s12325-018-0843-5.
- Rubin GP, Saunders CL, Abel GA, Mcphail S, Lyratzopoulos G, Neal RD. Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data. Br J Cancer. 2015;112:676–87. doi: 10.1038/ bjc.2014.634.
- Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014;110:584–92. doi: 10.1038/bjc.2013.791.
